ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,281,643 | +113.3% | 278,618 | +199.6% | 0.10% | +80.0% |
| Q2 2023 | $600,858 | +424.6% | 93,012 | +512.3% | 0.06% | +103.7% |
| Q1 2023 | $114,533 | +647.3% | 15,190 | +904.0% | 0.03% | +575.0% |
| Q4 2022 | $15,327 | +410.9% | 1,513 | +432.7% | 0.00% | +300.0% |
| Q3 2022 | $3,000 | -87.5% | 284 | -87.5% | 0.00% | -80.0% |
| Q2 2022 | $24,000 | -77.8% | 2,269 | -79.5% | 0.01% | -80.0% |
| Q1 2022 | $108,000 | +134.8% | 11,078 | +247.9% | 0.02% | +47.1% |
| Q4 2021 | $46,000 | +1433.3% | 3,184 | +1928.0% | 0.02% | +1600.0% |
| Q2 2021 | $3,000 | – | 157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |